Heart Disease in Type 2 Diabetes – New Stent Superior

The New England Journal of Medicine reports that a new stent to treat heart attacks, the XIENCE stent containing the drug everolimus is a better treatment for heart disease in patients with type 2 diabetes than the commonly used TAXUS paclitaxel-eluting stent. In patients with diabetes mellitus and coronary heart disease requiring a stent insertion, those receiving the XIENCE stent had lower rates of myocardial infarction, stent thrombosis (blockage) and reduced need for a repeat stent procedure.

WWW.NEJM.ORG

 

Back to Blog